DeLorean AI CEO Discusses Predictive Medicine and the Future of Healthcare AI

Dr. Severence MacLaughlin, founder and CEO of DeLorean AI, has been at the forefront of integrating artificial intelligence into healthcare to not just predict but also prevent chronic diseases. In a detailed discussion, MacLaughlin highlighted the company's milestones, including the development of a Customer Relationship Management AI that outperformed Salesforce's own AI 90% of the time, and the ability to predict Chronic Kidney Disease progression five years in advance with a biological confidence level of 95 to 99%.

MacLaughlin emphasized the importance of demonstrating real return on investment (ROI) to enterprise partners, citing a 50% reduction in hospitalizations within 90 days when their technology is used. This translates to significant financial savings, with nearly $1 billion saved for insurers and the Centers for Medicare & Medicaid Services. The success of DeLorean AI's deployments is measured by the seamless integration of their AI into healthcare practices, enabling physicians to improve patient outcomes with minimal additional effort.

Addressing the challenges of introducing new technologies to traditionally slow-moving healthcare institutions, MacLaughlin noted the importance of presenting real-world data to business and medical leaders. Despite the hurdles, smaller, physician-owned organizations have been more receptive to adopting DeLorean AI's technologies, recognizing both the health and financial benefits.

MacLaughlin's decision to bootstrap DeLorean AI has shaped the company's disciplined approach to growth and innovation. By funding the initial R&D phase himself, he ensured the company remained focused on its mission without external pressures. This strategy has fostered a culture of frugality and dedication among the team, united by the vision of making a tangible difference in patients' lives.

Looking ahead, MacLaughlin envisions DeLorean AI becoming the gold standard for quality in AI, akin to Intel's role in the computing revolution. With a focus on predictive medicine, the company aims to extend patients' lives and become a household name in the next five to ten years. For more information on DeLorean AI's innovative solutions, visit https://www.delorean.ai.